Advanced search
Publication Cover
Current Medical Research and Opinion Volume 33, 2017 - Issue 1
Submit an article Journal homepage
412
Views
4
CrossRef citations to date
0
Altmetric
Diabetes

Real world clinical outcomes and patient characteristics for canagliflozin treated patients in a specialty diabetes clinic

June Felice JohnsonDrake University College of Pharmacy and Health Sciences, Des MoinesIA, USA; Correspondence[email protected]
,
Rahul ParsaIowa State University College of Business, Ames, IA, USA;
&
Robert BaileyPopulation Health Research, Health Economics and Outcomes Research, Janssen Scientific Affairs, LLC, Titusville, NJ, USA
Pages 77-84 | Received 25 Jul 2016, Accepted 13 Sep 2016, Published online: 05 Oct 2016

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Damon Tanton, Mei Sheng Duh, Marie-Hélène Lafeuille, Patrick Lefebvre, Dominic Pilon, Maryia Zhdanava, Bruno Emond, Doreen Inman & Robert A. Bailey. (2018) Real-world evaluation of Hba1c, blood pressure, and weight loss among patients with type 2 diabetes mellitus treated with canagliflozin: an analysis of electronic medical records from a network of hospitals in Florida. Current Medical Research and Opinion 34:6, pages 1099-1115.
Read now

Articles from other publishers (3)

Juan J. Gorgojo-Martínez, Manuel A. Gargallo-Fernández, Alba Galdón Sanz-Pastor, Teresa Antón-Bravo, Miguel Brito-Sanfiel & Jaime Wong-Cruz. (2020) Real-World Clinical Outcomes Associated with Canagliflozin in Patients with Type 2 Diabetes Mellitus in Spain: The Real-Wecan Study. Journal of Clinical Medicine 9:7, pages 2275.
Crossref
Yun Shen, Jian Zhou, Lizheng Shi, Elizabeth Nauman, Peter T. Katzmarzyk, Eboni G. Price‐Haywood, Ronald Horswell, San Chu, Shengping Yang, Alessandra N. Bazzano, Somesh Nigam & Gang Hu. (2020) Effectiveness of sodium‐glucose co‐transporter‐2 inhibitors on ischaemic heart disease. Diabetes, Obesity and Metabolism 22:7, pages 1197-1206.
Crossref
June Felice Johnson, Rahul Parsa & Robert A. Bailey. (2017) Real-world Clinical Outcomes Among Patients With Type 2 Diabetes Receiving Canagliflozin at a Specialty Diabetes Clinic: Subgroup Analysis by Baseline HbA 1c and Age. Clinical Therapeutics 39:6, pages 1123-1131.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.